Altium Capital

Altium Capital is an alternative investment manager based in New York. Its work centres on long-term investment in healthcare companies developing new technologies for human health. It supplies growth capital to both private and public companies.

Services

• Growth capital: funding for early-stage ventures, including those still in pre-clinical development.
• Repeat financing: long-term partnerships with several rounds of investment in the same company.
• Capital introductions: help attracting further investors through its network.
• Research-led selection: investment decisions rest on its own research and due diligence.

Who it works with

Mostly therapeutics businesses, whether private ventures or small-cap and micro-cap listed companies, many of them raising money from institutions for the first time. Portfolio names shown include Antios Therapeutics, Cerevel Therapeutics, Chemomab Therapeutics, eGenesis and Immunovant.

Key facts

• Based in: New York
• Sector: healthcare
• Chief executive: Jacob Gottlieb, with more than 20 years in healthcare investing